Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Amyris stock | 2.32

Own Amyris stock in just a few minutes.


Fact checked

Amyris, Inc is a specialty chemicals business based in the US. Amyris shares (AMRS) are listed on the NASDAQ and all prices are listed in US Dollars. Amyris employs 561 staff and has a trailing 12-month revenue of around USD$134.6 million.

How to buy shares in Amyris

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Amyris. Find the stock by name or ticker symbol: AMRS. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Amyris reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$2.32, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Amyris, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Amyris. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Amyris's share price?

Since the stock market crash in March caused by coronavirus, Amyris's share price has had significant negative movement.

Its last market close was USD$2.32, which is 29.70% down on its pre-crash value of USD$3.3 and 65.71% up on the lowest point reached during the March crash when the shares fell as low as USD$1.4.

If you had bought USD$1,000 worth of Amyris shares at the start of February 2020, those shares would have been worth USD$678.32 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$811.19.

Amyris share price

Use our graph to track the performance of AMRS stocks over time.

Amyris shares at a glance

Information last updated 2020-10-20.
Latest market close USD$2.32
52-week range USD$1.4 - USD$6.07
50-day moving average USD$2.9534
200-day moving average USD$3.4717
Wall St. target price USD$10
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-3.388

Buy Amyris shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Stocks, Mutual funds, ETFs, Forex
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Amyris stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Amyris price performance over time

Historical closes compared with the close of $2.32 from 2020-11-16

1 week (2020-11-20) 0.87%
1 month (2020-10-30) -7.20%
3 months (2020-08-28) -31.36%
6 months (2020-05-29) -37.80%
1 year (2019-11-29) -42.29%
2 years (2018-11-29) -51.77%
3 years (2017-11-29) -35.38%
5 years (2015-11-27) 48.72%

Amyris financials

Revenue TTM USD$134.6 million
Gross profit TTM USD$11.9 million
Return on assets TTM -45.49%
Return on equity TTM 0%
Profit margin -250.11%
Book value $-1.791
Market capitalisation USD$579.1 million

TTM: trailing 12 months

Shorting Amyris shares

There are currently 24.5 million Amyris shares held short by investors – that's known as Amyris's "short interest". This figure is 6.1% up from 23.1 million last month.

There are a few different ways that this level of interest in shorting Amyris shares can be evaluated.

Amyris's "short interest ratio" (SIR)

Amyris's "short interest ratio" (SIR) is the quantity of Amyris shares currently shorted divided by the average quantity of Amyris shares traded daily (recently around 3.4 million). Amyris's SIR currently stands at 7.13. In other words for every 100,000 Amyris shares traded daily on the market, roughly 7130 shares are currently held short.

However Amyris's short interest can also be evaluated against the total number of Amyris shares, or, against the total number of tradable Amyris shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amyris's short interest could be expressed as 0.12% of the outstanding shares (for every 100,000 Amyris shares in existence, roughly 120 shares are currently held short) or 0.2482% of the tradable shares (for every 100,000 tradable Amyris shares, roughly 248 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Amyris.

Find out more about how you can short Amyris stock.

Amyris share dividends

We're not expecting Amyris to pay a dividend over the next 12 months.

Have Amyris's shares ever split?

Amyris's shares were split on a 1:15 basis on 6 June 2017. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Amyris shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Amyris shares which in turn could have impacted Amyris's share price.

Amyris share price volatility

Over the last 12 months, Amyris's shares have ranged in value from as little as $1.4 up to $6.07. A popular way to gauge a stock's volatility is its "beta".

AMRS.US volatility(beta: 0.54)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amyris's is 0.5433. This would suggest that Amyris's shares are less volatile than average (for this exchange).

Amyris overview

Amyris, Inc., a biotechnology company, develops technology that creates microbial strains to produce artemisinic acid, a precursor of artemisinin, an anti-malarial drug. The company's technology platform enables to engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into large volume, high-value ingredients. It applies technology platform to engineer, manufacture, and sell products for the clean health and beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site